$BCBP
BCB BANCORP INC

2022 Q3 Form 10-Q Financial Statement

#000122845422000029 Filed on August 04, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1
Revenue $34.40M $30.46M $27.72M
YoY Change 22.23% 8.77% -1.25%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $493.0K $642.0K $600.0K
YoY Change -45.22% -8.29% 0.0%
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense $3.449M $2.720M $2.652M
YoY Change -2.32% -30.96% -41.24%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $18.94M $14.37M $14.09M
YoY Change 61.61% 25.72% 39.98%
Income Tax $5.552M $4.209M $4.136M
% Of Pretax Income 29.31% 29.29% 29.36%
Net Earnings $13.39M $10.16M $9.952M
YoY Change 60.92% 26.25% 39.83%
Net Earnings / Revenue 38.93% 33.36% 35.9%
Basic Earnings Per Share $0.78 $0.59 $0.57
Diluted Earnings Per Share $771.6K $0.58 $0.56
COMMON SHARES
Basic Shares Outstanding 16.98M 17.00M 16.98M
Diluted Shares Outstanding 17.36M 17.40M 17.34M

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $221.0M $206.2M $396.7M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $22.51M $11.08M $11.65M
YoY Change 73.17% -19.86% -21.29%
Goodwill $5.200M $5.200M $5.200M
YoY Change -1.89% 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments $18.41M $18.97M $21.27M
YoY Change -21.78% -8.99% 16.36%
Other Assets $15.86M $13.58M $13.00M
YoY Change 17.5% -1.57% -1.52%
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $3.266B $3.073B $3.040B
YoY Change 9.45% 6.13% 6.59%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $12.10M $12.50M $12.20M
YoY Change -10.36% -12.62% -16.44%
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $12.10M $12.50M $12.20M
YoY Change -10.36% -12.62% -16.44%
LONG-TERM LIABILITIES
Long-Term Debt $37.45M $37.39M $37.30M
YoY Change 0.67% 0.51% 0.54%
Other Long-Term Liabilities $8.309M $9.231M $11.60M
YoY Change -16.91% -16.08% 17.17%
Total Long-Term Liabilities $45.76M $46.62M $48.90M
YoY Change -3.05% -3.27% 4.04%
TOTAL LIABILITIES
Total Short-Term Liabilities $12.10M $12.50M $12.20M
Total Long-Term Liabilities $45.76M $46.62M $48.90M
Total Liabilities $2.983B $2.801B $2.764B
YoY Change 9.64% 6.24% 6.35%
SHAREHOLDERS EQUITY
Retained Earnings $105.9M $95.39M $88.13M
YoY Change 44.29% 40.03% 40.39%
Common Stock $195.1M $194.6M $194.2M
YoY Change 0.75% 0.83% 0.82%
Preferred Stock $21.00M $16.56M $26.21M
YoY Change -18.35% -35.61% 1.9%
Treasury Stock (at cost) $33.12M $31.89M $31.13M
YoY Change 12.55% 13.09% 13.92%
Treasury Stock Shares $2.885M $2.813M $2.769M
Shareholders Equity $282.7M $271.6M $276.2M
YoY Change
Total Liabilities & Shareholders Equity $3.266B $3.073B $3.040B
YoY Change 9.45% 6.13% 6.59%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1
OPERATING ACTIVITIES
Net Income $13.39M $10.16M $9.952M
YoY Change 60.92% 26.25% 39.83%
Depreciation, Depletion And Amortization $493.0K $642.0K $600.0K
YoY Change -45.22% -8.29% 0.0%
Cash From Operating Activities $13.02M $7.944M $11.75M
YoY Change 10.31% 15.13% -18.21%
INVESTING ACTIVITIES
Capital Expenditures -$140.0K -$81.00K $38.00K
YoY Change 40.0% -75.95%
Acquisitions
YoY Change
Other Investing Activities -$181.5M -$224.2M -$91.00M
YoY Change -960.09% 2418.88% 2359.46%
Cash From Investing Activities -$181.6M -$224.3M -$90.99M
YoY Change -964.85% 2419.79% 2245.76%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $8.000K
YoY Change -98.06%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 183.5M 25.76M 64.26M
YoY Change 124.0% -22.64% 154.81%
NET CHANGE
Cash From Operating Activities 13.02M 7.944M 11.75M
Cash From Investing Activities -181.6M -224.3M -90.99M
Cash From Financing Activities 183.5M 25.76M 64.26M
Net Change In Cash 14.85M -190.6M -14.98M
YoY Change -87.05% -708.81% -141.94%
FREE CASH FLOW
Cash From Operating Activities $13.02M $7.944M $11.75M
Capital Expenditures -$140.0K -$81.00K $38.00K
Free Cash Flow $13.16M $8.025M $11.71M
YoY Change 10.56% 16.3% -17.57%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
bcbp Share Based Compensation Shares Authorized Under Stock Option Plan Options Expired Exercise Price Range
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlanOptionsExpiredExercisePriceRange
bcbp Share Based Compensation Shares Authorized Under Stock Option Plan Options Forfeited Exercise Price Range
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlanOptionsForfeitedExercisePriceRange
bcbp Share Based Compensation Shares Authorized Under Stock Option Plan Options Granted Exercise Price Range
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlanOptionsGrantedExercisePriceRange
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
11129000
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
0-50275
dei Entity Registrant Name
EntityRegistrantName
BCB Bancorp, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NJ
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
26-0065262
dei Entity Address Address Line1
EntityAddressAddressLine1
104-110 Avenue C
dei Entity Address City Or Town
EntityAddressCityOrTown
Bayonne
dei Entity Address State Or Province
EntityAddressStateOrProvince
NJ
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
07002
dei City Area Code
CityAreaCode
201
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Entity Central Index Key
EntityCentralIndexKey
0001228454
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q2 us-gaap Preferred Stock Value
PreferredStockValue
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
dei Local Phone Number
LocalPhoneNumber
823-0700
CY2022Q2 us-gaap Bank Owned Life Insurance
BankOwnedLifeInsurance
70426000
dei Security12b Title
Security12bTitle
Common Stock, no par value
dei Trading Symbol
TradingSymbol
BCBP
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
16981867
CY2022Q2 us-gaap Cash And Due From Banks
CashAndDueFromBanks
10182000
CY2021Q4 us-gaap Cash And Due From Banks
CashAndDueFromBanks
9606000
CY2022Q2 us-gaap Interest Bearing Deposits In Banks
InterestBearingDepositsInBanks
195990000
CY2021Q4 us-gaap Interest Bearing Deposits In Banks
InterestBearingDepositsInBanks
402023000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
206172000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
411629000
CY2022Q2 us-gaap Certificates Of Deposit At Carrying Value
CertificatesOfDepositAtCarryingValue
735000
CY2021Q4 us-gaap Certificates Of Deposit At Carrying Value
CertificatesOfDepositAtCarryingValue
735000
CY2022Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
86749000
CY2021Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
85186000
CY2022Q2 us-gaap Equity Method Investments
EquityMethodInvestments
18968000
CY2021Q4 us-gaap Equity Method Investments
EquityMethodInvestments
25187000
CY2022Q2 us-gaap Loans Receivable Held For Sale Net Not Part Of Disposal Group
LoansReceivableHeldForSaleNetNotPartOfDisposalGroup
5000
CY2021Q4 us-gaap Loans Receivable Held For Sale Net Not Part Of Disposal Group
LoansReceivableHeldForSaleNetNotPartOfDisposalGroup
952000
CY2022Q2 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
34113000
CY2021Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
37119000
CY2022Q2 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
2620630000
CY2021Q4 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
2304942000
CY2022Q2 us-gaap Federal Home Loan Bank Stock
FederalHomeLoanBankStock
6781000
CY2021Q4 us-gaap Federal Home Loan Bank Stock
FederalHomeLoanBankStock
6084000
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11075000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
12237000
CY2022Q2 us-gaap Interest Receivable
InterestReceivable
10315000
CY2021Q4 us-gaap Interest Receivable
InterestReceivable
9183000
CY2022Q2 us-gaap Other Real Estate
OtherRealEstate
75000
CY2021Q4 us-gaap Other Real Estate
OtherRealEstate
75000
CY2022Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
13583000
CY2021Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
12959000
CY2022Q2 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
5406000
CY2021Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
5431000
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
12194000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
12457000
CY2021Q4 us-gaap Other Liabilities
OtherLiabilities
10364000
CY2022Q2 us-gaap Liabilities
Liabilities
2801134000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
81171000
CY2022Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2997000
CY2021Q4 us-gaap Bank Owned Life Insurance
BankOwnedLifeInsurance
72485000
CY2022Q2 us-gaap Other Assets
OtherAssets
9657000
CY2021Q4 us-gaap Other Assets
OtherAssets
7986000
CY2022Q2 us-gaap Assets
Assets
3072771000
CY2021Q4 us-gaap Assets
Assets
2967528000
CY2022Q2 us-gaap Noninterest Bearing Deposit Liabilities Domestic
NoninterestBearingDepositLiabilitiesDomestic
595167000
CY2021Q4 us-gaap Noninterest Bearing Deposit Liabilities Domestic
NoninterestBearingDepositLiabilitiesDomestic
588207000
CY2022Q2 us-gaap Interest Bearing Deposit Liabilities Domestic
InterestBearingDepositLiabilitiesDomestic
2059863000
CY2021Q4 us-gaap Interest Bearing Deposit Liabilities Domestic
InterestBearingDepositLiabilitiesDomestic
1973195000
CY2022Q2 us-gaap Deposits
Deposits
2655030000
CY2021Q4 us-gaap Deposits
Deposits
2561402000
CY2022Q2 us-gaap Federal Home Loan Bank Advances Branch Of Fhlb Bank Amount Of Advances By Branch
FederalHomeLoanBankAdvancesBranchOfFHLBBankAmountOfAdvancesByBranch
86986000
CY2021Q4 us-gaap Federal Home Loan Bank Advances Branch Of Fhlb Bank Amount Of Advances By Branch
FederalHomeLoanBankAdvancesBranchOfFHLBBankAmountOfAdvancesByBranch
71711000
CY2022Q2 us-gaap Subordinated Debt
SubordinatedDebt
37391000
CY2021Q4 us-gaap Subordinated Debt
SubordinatedDebt
37275000
CY2022Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
12496000
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
12752000
CY2022Q2 us-gaap Other Liabilities
OtherLiabilities
9231000
CY2021Q4 us-gaap Liabilities
Liabilities
2693504000
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2022Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
2645
CY2022Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
2645
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
2916
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
2916
CY2022Q2 us-gaap Additional Paid In Capital Preferred Stock
AdditionalPaidInCapitalPreferredStock
16563000
CY2021Q4 us-gaap Additional Paid In Capital Preferred Stock
AdditionalPaidInCapitalPreferredStock
28923000
CY2021Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2022Q2 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
19753295
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
19708375
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
16984538
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
16940133
CY2022Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
194567000
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
193927000
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
95393000
CY2021Q2 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
28004000
us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
58185000
us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
56079000
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1128000
us-gaap Interest Income Other
InterestIncomeOther
1887000
CY2022Q2 us-gaap Interest Expense Demand Deposit Accounts
InterestExpenseDemandDepositAccounts
946000
CY2021Q2 us-gaap Interest Expense Demand Deposit Accounts
InterestExpenseDemandDepositAccounts
1150000
CY2022Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
2813355
CY2021Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
2768242
CY2022Q2 us-gaap Treasury Stock Value
TreasuryStockValue
31889000
CY2021Q4 us-gaap Treasury Stock Value
TreasuryStockValue
31125000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
271637000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
274024000
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3072771000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2967528000
CY2022Q2 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
28781000
CY2021Q2 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
26888000
us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
55102000
us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
53751000
CY2022Q2 us-gaap Interest Income Securities Mortgage Backed
InterestIncomeSecuritiesMortgageBacked
47000
CY2021Q2 us-gaap Interest Income Securities Mortgage Backed
InterestIncomeSecuritiesMortgageBacked
167000
us-gaap Interest Income Securities Mortgage Backed
InterestIncomeSecuritiesMortgageBacked
206000
us-gaap Interest Income Securities Mortgage Backed
InterestIncomeSecuritiesMortgageBacked
373000
CY2022Q2 us-gaap Interest Income Other
InterestIncomeOther
939000
CY2021Q2 us-gaap Interest Income Other
InterestIncomeOther
747000
us-gaap Interest Income Other
InterestIncomeOther
1531000
CY2022Q2 us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
694000
CY2021Q2 us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
202000
us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
990000
us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
424000
CY2022Q2 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
30461000
us-gaap Interest Expense Demand Deposit Accounts
InterestExpenseDemandDepositAccounts
1704000
us-gaap Interest Expense Demand Deposit Accounts
InterestExpenseDemandDepositAccounts
2348000
CY2022Q2 us-gaap Interest Expense Savings Deposits
InterestExpenseSavingsDeposits
110000
CY2021Q2 us-gaap Interest Expense Savings Deposits
InterestExpenseSavingsDeposits
127000
us-gaap Interest Expense Savings Deposits
InterestExpenseSavingsDeposits
218000
us-gaap Interest Expense Savings Deposits
InterestExpenseSavingsDeposits
245000
CY2022Q2 us-gaap Interest Expense Time Deposits
InterestExpenseTimeDeposits
849000
CY2021Q2 us-gaap Interest Expense Time Deposits
InterestExpenseTimeDeposits
1639000
us-gaap Interest Expense Time Deposits
InterestExpenseTimeDeposits
1829000
us-gaap Interest Expense Time Deposits
InterestExpenseTimeDeposits
3631000
CY2022Q2 us-gaap Interest Expense Deposits
InterestExpenseDeposits
1905000
CY2021Q2 us-gaap Interest Expense Deposits
InterestExpenseDeposits
2916000
us-gaap Interest Expense Deposits
InterestExpenseDeposits
3751000
CY2022Q2 us-gaap Underwriting Income Loss
UnderwritingIncomeLoss
1213000
CY2021Q2 bcbp Gain Loss On Bulk Sale Of Impaired Loans Held In Portfolio
GainLossOnBulkSaleOfImpairedLoansHeldInPortfolio
-64000
us-gaap Interest Expense Deposits
InterestExpenseDeposits
6224000
CY2022Q2 us-gaap Interest Expense Borrowings
InterestExpenseBorrowings
815000
CY2021Q2 us-gaap Interest Expense Borrowings
InterestExpenseBorrowings
1024000
us-gaap Interest Expense Borrowings
InterestExpenseBorrowings
1621000
us-gaap Interest Expense Borrowings
InterestExpenseBorrowings
2229000
CY2022Q2 us-gaap Interest Expense
InterestExpense
2720000
CY2021Q2 us-gaap Interest Expense
InterestExpense
3940000
us-gaap Interest Expense
InterestExpense
5372000
us-gaap Interest Expense
InterestExpense
8453000
CY2022Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
27741000
CY2021Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
24064000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
52813000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
47626000
CY2021Q2 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
2295000
us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
-2575000
us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
4160000
CY2022Q2 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
27741000
CY2021Q2 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
21769000
us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
55388000
us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
43466000
CY2021Q2 us-gaap Underwriting Income Loss
UnderwritingIncomeLoss
1029000
us-gaap Underwriting Income Loss
UnderwritingIncomeLoss
2427000
us-gaap Underwriting Income Loss
UnderwritingIncomeLoss
2140000
CY2022Q2 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
686000
CY2021Q2 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
729000
us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
1441000
us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
1430000
CY2022Q2 us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
43000
CY2021Q2 us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
218000
us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
108000
us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
492000
bcbp Gain Loss On Bulk Sale Of Impaired Loans Held In Portfolio
GainLossOnBulkSaleOfImpairedLoansHeldInPortfolio
-64000
CY2021Q2 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
371000
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
371000
CY2022Q2 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-2302000
CY2021Q2 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
499000
us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-4987000
us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
303000
CY2022Q2 us-gaap Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
47000
CY2021Q2 us-gaap Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
38000
us-gaap Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
98000
us-gaap Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
98000
CY2022Q2 us-gaap Noninterest Income
NoninterestIncome
-313000
CY2021Q2 us-gaap Noninterest Income
NoninterestIncome
2820000
us-gaap Noninterest Income
NoninterestIncome
-913000
us-gaap Noninterest Income
NoninterestIncome
4770000
CY2022Q2 us-gaap Labor And Related Expense
LaborAndRelatedExpense
6715000
CY2021Q2 us-gaap Labor And Related Expense
LaborAndRelatedExpense
6512000
us-gaap Labor And Related Expense
LaborAndRelatedExpense
13451000
bcbp Regulatory Assessments
RegulatoryAssessments
548000
CY2022Q2 us-gaap Other Noninterest Expense
OtherNoninterestExpense
912000
us-gaap Labor And Related Expense
LaborAndRelatedExpense
13057000
CY2022Q2 us-gaap Occupancy Net
OccupancyNet
2673000
CY2021Q2 us-gaap Occupancy Net
OccupancyNet
2668000
us-gaap Occupancy Net
OccupancyNet
5368000
us-gaap Occupancy Net
OccupancyNet
5621000
CY2022Q2 us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
1469000
CY2021Q2 us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
1527000
us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
2934000
us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
2982000
CY2022Q2 us-gaap Professional Fees
ProfessionalFees
489000
CY2021Q2 us-gaap Professional Fees
ProfessionalFees
491000
us-gaap Professional Fees
ProfessionalFees
983000
us-gaap Professional Fees
ProfessionalFees
903000
CY2022Q2 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
296000
CY2021Q2 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
310000
us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
617000
us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
557000
CY2022Q2 bcbp Regulatory Assessments
RegulatoryAssessments
244000
CY2021Q2 bcbp Regulatory Assessments
RegulatoryAssessments
314000
bcbp Regulatory Assessments
RegulatoryAssessments
690000
CY2022Q2 us-gaap Advertising Expense
AdvertisingExpense
254000
CY2021Q2 us-gaap Advertising Expense
AdvertisingExpense
109000
us-gaap Advertising Expense
AdvertisingExpense
395000
us-gaap Advertising Expense
AdvertisingExpense
193000
CY2022Q2 us-gaap Foreclosed Real Estate Expense
ForeclosedRealEstateExpense
4000
CY2021Q2 us-gaap Foreclosed Real Estate Expense
ForeclosedRealEstateExpense
19000
us-gaap Foreclosed Real Estate Expense
ForeclosedRealEstateExpense
5000
us-gaap Foreclosed Real Estate Expense
ForeclosedRealEstateExpense
23000
CY2021Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-194000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-734000
CY2021Q2 us-gaap Other Noninterest Expense
OtherNoninterestExpense
1013000
us-gaap Other Noninterest Expense
OtherNoninterestExpense
1714000
us-gaap Other Noninterest Expense
OtherNoninterestExpense
1980000
CY2022Q2 us-gaap Noninterest Expense
NoninterestExpense
13056000
CY2021Q2 us-gaap Noninterest Expense
NoninterestExpense
13157000
us-gaap Noninterest Expense
NoninterestExpense
26015000
us-gaap Noninterest Expense
NoninterestExpense
26740000
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
14372000
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
11432000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
28460000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
21496000
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4209000
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3382000
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
256000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.16
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.85
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-4125000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8345000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6329000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
10163000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
8050000
us-gaap Net Income Loss
NetIncomeLoss
20115000
us-gaap Net Income Loss
NetIncomeLoss
15167000
CY2022Q2 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
138000
CY2021Q2 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
284000
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
414000
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
567000
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
10025000
CY2021Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
7766000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
19701000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
14600000
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.59
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.45
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.58
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.45
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.13
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.85
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16997000
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17126000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16989000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17120000
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17404000
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17282000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17375000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17257000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
10163000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
8050000
us-gaap Net Income Loss
NetIncomeLoss
20115000
us-gaap Net Income Loss
NetIncomeLoss
15167000
CY2022Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
-2290000
CY2021Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
341000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
-5485000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
149000
CY2022Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-568000
CY2021Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
85000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-1360000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
37000
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1722000
CY2022Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
133000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
271637000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
276159000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
112000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
10163000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
116000
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
8441000
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
8306000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
15990000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
15279000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
274024000
us-gaap Net Income Loss
NetIncomeLoss
20115000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-4125000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
191000
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
45113
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
764000
us-gaap Dividends Preferred Stock
DividendsPreferredStock
450000
us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
14730000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2370000
us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.32
us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
5213000
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
219000
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1722000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
96000
CY2022Q2 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
44598
CY2022Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
756000
CY2022Q2 us-gaap Dividends Preferred Stock
DividendsPreferredStock
174000
CY2022Q2 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
9650000
CY2022Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.16
CY2022Q2 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
2612000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
271637000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
249211000
us-gaap Net Income Loss
NetIncomeLoss
15167000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
112000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
251000
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
97875
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
1279000
us-gaap Dividends Preferred Stock
DividendsPreferredStock
567000
us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.28
us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
4593000
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
222000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
258524000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
253454000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
8050000
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
256000
bcbp Gain Loss On Bulk Sale Of Impaired Loans Held In Portfolio
GainLossOnBulkSaleOfImpairedLoansHeldInPortfolio
-64000
CY2021Q2 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
67782
CY2021Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
867000
CY2021Q2 us-gaap Dividends Preferred Stock
DividendsPreferredStock
284000
CY2021Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.14
CY2021Q2 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
2312000
CY2021Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
111000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
258524000
us-gaap Net Income Loss
NetIncomeLoss
20115000
us-gaap Net Income Loss
NetIncomeLoss
15167000
us-gaap Depreciation Nonproduction
DepreciationNonproduction
1242000
us-gaap Depreciation Nonproduction
DepreciationNonproduction
1280000
bcbp Amortization And Accretion Net
AmortizationAndAccretionNet
522000
bcbp Amortization And Accretion Net
AmortizationAndAccretionNet
428000
us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
-2575000
us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
4160000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
736000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1241000
us-gaap Payments For Origination Of Mortgage Loans Held For Sale
PaymentsForOriginationOfMortgageLoansHeldForSale
4856000
us-gaap Payments For Origination Of Mortgage Loans Held For Sale
PaymentsForOriginationOfMortgageLoansHeldForSale
19621000
us-gaap Proceeds From Sale Of Mortgage Loans Held For Sale
ProceedsFromSaleOfMortgageLoansHeldForSale
5911000
us-gaap Proceeds From Sale Of Mortgage Loans Held For Sale
ProceedsFromSaleOfMortgageLoansHeldForSale
20489000
us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
108000
us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
492000
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
371000
us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-4987000
us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
303000
us-gaap Share Based Compensation
ShareBasedCompensation
191000
us-gaap Share Based Compensation
ShareBasedCompensation
251000
us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
1441000
us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
1430000
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
1132000
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-2303000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
1671000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-824000
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-46000
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-265000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-1087000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
938000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
19744000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
21325000
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
8118000
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
24388000
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
15488000
us-gaap Proceeds From Federal Home Loan Bank Borrowings
ProceedsFromFederalHomeLoanBankBorrowings
15000000
us-gaap Proceeds From Federal Home Loan Bank Borrowings
ProceedsFromFederalHomeLoanBankBorrowings
10000000
us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
93628000
us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
127764000
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1174725
us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
9.02
us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
13.68
bcbp Proceeds From Bulk Sale Of Impaired Loans
ProceedsFromBulkSaleOfImpairedLoans
2364000
us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
1232000
us-gaap Payments For Proceeds From Loans Receivable
PaymentsForProceedsFromLoansReceivable
311845000
us-gaap Payments For Proceeds From Loans Receivable
PaymentsForProceedsFromLoansReceivable
22954000
us-gaap Payments To Acquire Life Insurance Policies
PaymentsToAcquireLifeInsurancePolicies
8500000
us-gaap Proceeds From Life Insurance Policies
ProceedsFromLifeInsurancePolicies
3500000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
81000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
198000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
742000
us-gaap Payments For Proceeds From Federal Home Loan Bank Stock
PaymentsForProceedsFromFederalHomeLoanBankStock
697000
us-gaap Payments For Proceeds From Federal Home Loan Bank Stock
PaymentsForProceedsFromFederalHomeLoanBankStock
-2443000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-315261000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-12844000
us-gaap Repayments Of Federal Home Loan Bank Borrowings
RepaymentsOfFederalHomeLoanBankBorrowings
73000000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
764000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1279000
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
5213000
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
4593000
us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
450000
us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
567000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
219000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
222000
us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
2370000
us-gaap Payments For Repurchase Of Redeemable Preferred Stock
PaymentsForRepurchaseOfRedeemablePreferredStock
14730000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
90060000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
58547000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-205457000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
67028000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
411629000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
261229000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
206172000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
328257000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
9948000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
6800000
us-gaap Interest Paid Net
InterestPaidNet
5419000
us-gaap Interest Paid Net
InterestPaidNet
8718000
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
11.63
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
88000
CY2021Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
156000
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
110000
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
10025000
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17404000
bcbp Share Based Compensation Shares Authorized Under Stock Option Plan Options Granted Exercise Price Range Lower Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlanOptionsGrantedExercisePriceRangeLowerRangeLimit
10.55
bcbp Share Based Compensation Shares Authorized Under Stock Option Plan Options Granted Exercise Price Range Upper Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlanOptionsGrantedExercisePriceRangeUpperRangeLimit
13.68
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
11.92
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.58
us-gaap Reclassifications
Reclassifications
<span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Note 3 – Reclassification </span><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Certain amounts as of December 31, 2021 and for the six month period ended June 30, 2021 have been reclassified to conform to the current period’s presentation. These changes had no effect on the Company’s results of operations or financial position.</span></p>
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
26700
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
12.89
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
33000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
16.00
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
6750
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
12.89
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
52950
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
14.83
us-gaap Restricted Stock Expense
RestrictedStockExpense
54000
us-gaap Restricted Stock Expense
RestrictedStockExpense
141000
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1194425
CY2021 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
9.02
CY2021 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
13.68
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
11.64
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
19700
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.45
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.16
CY2021Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
37119000
CY2022Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
407000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
14600000
CY2022Q2 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
2620630000
CY2022Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0
CY2021Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8410
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
14723
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
10025000
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16997000
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.59
CY2021Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
7766000
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17126000
CY2021Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
7766000
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17282000
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.45
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
19701000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16989000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17120000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.85
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
386000
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
137000
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
19701000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17375000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.13
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
14600000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17257000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.85
CY2022Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
3318000
CY2022Q2 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-2302000
CY2021Q2 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
499000
CY2022Q2 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
2657882000
CY2021Q4 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
2343937000
CY2022Q2 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-2302000
CY2021Q2 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
499000
us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-4928000
us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
303000
us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
-59000
us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-4987000
us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
303000
CY2022Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
89794000
CY2022Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
273000
CY2022Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
86749000
CY2021Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
82746000
CY2021Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
3027000
CY2021Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
587000
CY2021Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
85186000
CY2022Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
55123000
CY2022Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
2654000
CY2022Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
3520000
CY2022Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
664000
CY2022Q2 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
58643000
CY2022Q2 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
3318000
CY2021Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
20125000
CY2021Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
318000
CY2021Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
4681000
CY2021Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
269000
CY2021Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
24806000
CY2021Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
587000
us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
772000
us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
341000
CY2021Q2 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
37472000
CY2022Q2 us-gaap Loans And Leases Receivable Deferred Income
LoansAndLeasesReceivableDeferredIncome
3139000
us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
-2575000
CY2022Q2 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
34113000
CY2021Q4 us-gaap Loans And Leases Receivable Deferred Income
LoansAndLeasesReceivableDeferredIncome
1876000
CY2022Q2 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
34113000
CY2021Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
35477000
CY2021Q2 us-gaap Impaired Financing Receivable With No Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment
40941000
CY2021Q2 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
304000
CY2021Q4 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
2304942000
CY2022Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
33980000
CY2022Q2 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
6000
CY2022Q2 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
139000
CY2022Q2 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
34113000
CY2022Q2 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
6333000
CY2022Q2 us-gaap Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
27780000
CY2022Q2 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
34113000
CY2022Q2 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
42411000
CY2022Q2 us-gaap Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
2615471000
CY2022Q2 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
2657882000
CY2021Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
37119000
CY2021Q2 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
4000
CY2021Q2 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
2295000
CY2021Q2 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
37472000
CY2021Q2 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
6969000
CY2021Q2 us-gaap Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
30503000
CY2021Q2 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
62281000
CY2021Q2 us-gaap Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
2289165000
CY2021Q2 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
2351446000
CY2020Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
33639000
us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
361000
us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
34000
us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
4160000
CY2021Q2 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
37472000
CY2021Q4 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
7828000
CY2021Q4 us-gaap Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
29291000
CY2021Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
37119000
CY2021Q4 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
49382000
CY2021Q4 us-gaap Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
2294555000
CY2021Q4 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
2343937000
CY2022Q2 us-gaap Impaired Financing Receivable With No Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment
29185000
CY2022Q2 us-gaap Impaired Financing Receivable With No Related Allowance Interest Income Accrual Method
ImpairedFinancingReceivableWithNoRelatedAllowanceInterestIncomeAccrualMethod
369000
us-gaap Impaired Financing Receivable Interest Income Accrual Method
ImpairedFinancingReceivableInterestIncomeAccrualMethod
1134000
CY2021Q4 us-gaap Impaired Financing Receivable With No Related Allowance Unpaid Principal Balance
ImpairedFinancingReceivableWithNoRelatedAllowanceUnpaidPrincipalBalance
33085000
CY2022Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3046000
CY2021Q2 us-gaap Impaired Financing Receivable With No Related Allowance Interest Income Accrual Method
ImpairedFinancingReceivableWithNoRelatedAllowanceInterestIncomeAccrualMethod
353000
us-gaap Impaired Financing Receivable With No Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment
28376000
us-gaap Impaired Financing Receivable With No Related Allowance Interest Income Accrual Method
ImpairedFinancingReceivableWithNoRelatedAllowanceInterestIncomeAccrualMethod
739000
us-gaap Impaired Financing Receivable With No Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment
50163000
us-gaap Impaired Financing Receivable With No Related Allowance Interest Income Accrual Method
ImpairedFinancingReceivableWithNoRelatedAllowanceInterestIncomeAccrualMethod
728000
CY2022Q2 us-gaap Impaired Financing Receivable With Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment
12499000
CY2022Q2 us-gaap Impaired Financing Receivable With Related Allowance Interest Income Accrual Method
ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAccrualMethod
25000
CY2021Q2 us-gaap Impaired Financing Receivable With Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment
23869000
CY2021Q2 us-gaap Impaired Financing Receivable With Related Allowance Interest Income Accrual Method
ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAccrualMethod
196000
us-gaap Impaired Financing Receivable With Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment
15873000
us-gaap Impaired Financing Receivable With Related Allowance Interest Income Accrual Method
ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAccrualMethod
395000
us-gaap Impaired Financing Receivable With Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment
20777000
us-gaap Impaired Financing Receivable With Related Allowance Interest Income Accrual Method
ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAccrualMethod
452000
CY2022Q2 us-gaap Impaired Financing Receivable Average Recorded Investment
ImpairedFinancingReceivableAverageRecordedInvestment
41684000
CY2022Q2 us-gaap Impaired Financing Receivable Interest Income Accrual Method
ImpairedFinancingReceivableInterestIncomeAccrualMethod
394000
CY2021Q2 us-gaap Impaired Financing Receivable Average Recorded Investment
ImpairedFinancingReceivableAverageRecordedInvestment
64810000
CY2021Q2 us-gaap Impaired Financing Receivable Interest Income Accrual Method
ImpairedFinancingReceivableInterestIncomeAccrualMethod
549000
us-gaap Impaired Financing Receivable Average Recorded Investment
ImpairedFinancingReceivableAverageRecordedInvestment
44249000
us-gaap Impaired Financing Receivable Average Recorded Investment
ImpairedFinancingReceivableAverageRecordedInvestment
70940000
us-gaap Impaired Financing Receivable Interest Income Accrual Method
ImpairedFinancingReceivableInterestIncomeAccrualMethod
1180000
CY2022Q2 us-gaap Impaired Financing Receivable With No Related Allowance Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment
31688000
CY2022Q2 us-gaap Impaired Financing Receivable With No Related Allowance Unpaid Principal Balance
ImpairedFinancingReceivableWithNoRelatedAllowanceUnpaidPrincipalBalance
33487000
CY2021Q4 us-gaap Impaired Financing Receivable With No Related Allowance Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment
26758000
CY2022Q2 us-gaap Impaired Financing Receivable With Related Allowance Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment
10723000
CY2022Q2 us-gaap Impaired Financing Receivable With Related Allowance Unpaid Principal Balance
ImpairedFinancingReceivableWithRelatedAllowanceUnpaidPrincipalBalance
21566000
CY2022Q2 us-gaap Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
6333000
CY2021Q4 us-gaap Impaired Financing Receivable With Related Allowance Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment
22624000
CY2021Q4 us-gaap Impaired Financing Receivable With Related Allowance Unpaid Principal Balance
ImpairedFinancingReceivableWithRelatedAllowanceUnpaidPrincipalBalance
37191000
CY2021Q4 us-gaap Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
7828000
CY2022Q2 us-gaap Impaired Financing Receivable Recorded Investment
ImpairedFinancingReceivableRecordedInvestment
42411000
CY2022Q2 us-gaap Impaired Financing Receivable Unpaid Principal Balance
ImpairedFinancingReceivableUnpaidPrincipalBalance
55053000
CY2022Q2 us-gaap Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
6333000
CY2021Q4 us-gaap Impaired Financing Receivable Recorded Investment
ImpairedFinancingReceivableRecordedInvestment
49382000
CY2021Q4 us-gaap Impaired Financing Receivable Unpaid Principal Balance
ImpairedFinancingReceivableUnpaidPrincipalBalance
70276000
CY2021Q4 us-gaap Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
7828000
CY2021Q4 us-gaap Financing Receivable Recorded Investment90 Days Past Due And Still Accruing
FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
3124000
CY2022Q2 us-gaap Financing Receivable Modifications Recorded Investment
FinancingReceivableModificationsRecordedInvestment
11364000
CY2021Q4 us-gaap Financing Receivable Modifications Recorded Investment
FinancingReceivableModificationsRecordedInvestment
15972000
CY2022Q2 us-gaap Financing Receivable Modifications Number Of Contracts2
FinancingReceivableModificationsNumberOfContracts2
0
CY2021Q2 us-gaap Financing Receivable Modifications Number Of Contracts2
FinancingReceivableModificationsNumberOfContracts2
3
CY2021Q2 us-gaap Financing Receivable Modifications Post Modification Recorded Investment2
FinancingReceivableModificationsPostModificationRecordedInvestment2
3225525
CY2022Q2 us-gaap Financing Receivable Modifications Subsequent Default Recorded Investment1
FinancingReceivableModificationsSubsequentDefaultRecordedInvestment1
0
CY2021Q2 us-gaap Financing Receivable Modifications Subsequent Default Recorded Investment1
FinancingReceivableModificationsSubsequentDefaultRecordedInvestment1
134537
CY2021Q2 us-gaap Financing Receivable Modifications Subsequent Default Number Of Contracts1
FinancingReceivableModificationsSubsequentDefaultNumberOfContracts1
1
CY2022Q2 us-gaap Notes Receivable Gross
NotesReceivableGross
2657882000
CY2021Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
2343937000
CY2021Q4 us-gaap Certain Loans Acquired In Transfer Accounted For As Debt Securities Acquired During Period At Acquisition At Fair Value
CertainLoansAcquiredInTransferAccountedForAsDebtSecuritiesAcquiredDuringPeriodAtAcquisitionAtFairValue
670000
CY2022Q2 us-gaap Certain Loans Acquired In Transfer Accounted For As Debt Securities Acquired During Period At Acquisition At Fair Value
CertainLoansAcquiredInTransferAccountedForAsDebtSecuritiesAcquiredDuringPeriodAtAcquisitionAtFairValue
670000
CY2022Q2 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
9201000
CY2021Q4 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
14889000
us-gaap Loans And Leases Receivable Impaired Interest Lost On Nonaccrual Loans
LoansAndLeasesReceivableImpairedInterestLostOnNonaccrualLoans
481000
CY2021 us-gaap Loans And Leases Receivable Impaired Interest Lost On Nonaccrual Loans
LoansAndLeasesReceivableImpairedInterestLostOnNonaccrualLoans
1300000
CY2022Q2 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
2657882000
CY2021Q4 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
2343937000
us-gaap Payments To Acquire Life Insurance Policies
PaymentsToAcquireLifeInsurancePolicies
8500000
CY2022Q2 us-gaap Life Insurance Corporate Or Bank Owned Amount
LifeInsuranceCorporateOrBankOwnedAmount
70400000
us-gaap Variable Lease Cost
VariableLeaseCost
490000
CY2021Q4 us-gaap Other Real Estate
OtherRealEstate
75000
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
12194000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
12457000
us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0
CY2022Q2 us-gaap Goodwill
Goodwill
5200000
CY2021Q2 us-gaap Goodwill
Goodwill
5200000
CY2021Q2 bcbp Transfers Between Fair Value Hierarchies Assets Liabilities
TransfersBetweenFairValueHierarchiesAssetsLiabilities
0
CY2022Q2 bcbp Transfers Between Fair Value Hierarchies Assets Liabilities
TransfersBetweenFairValueHierarchiesAssetsLiabilities
0
CY2022Q2 us-gaap Loans Receivable Fair Value Disclosure
LoansReceivableFairValueDisclosure
4390000
CY2022Q2 us-gaap Other Real Estate
OtherRealEstate
75000
CY2021Q4 us-gaap Loans Receivable Fair Value Disclosure
LoansReceivableFairValueDisclosure
14796000
CY2022Q2 us-gaap Other Real Estate
OtherRealEstate
75000
bcbp Lessee Operating Leases Number
LesseeOperatingLeasesNumber
28
CY2022Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
938000
CY2021Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
932000
us-gaap Operating Lease Cost
OperatingLeaseCost
1840000
us-gaap Operating Lease Cost
OperatingLeaseCost
1884000
CY2022Q2 us-gaap Variable Lease Cost
VariableLeaseCost
257000
CY2021Q2 us-gaap Variable Lease Cost
VariableLeaseCost
244000
us-gaap Variable Lease Cost
VariableLeaseCost
476000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
2679000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3296000
CY2022Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
10415000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
3046000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
10529000
CY2022Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
965000
CY2021Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1073000
CY2022Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
12496000
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
12752000
CY2022Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y9M
CY2021Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y11M26D
CY2022Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0238
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0260
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
3296000
CY2022Q2 bcbp Lessee Operating Lease Liability Payments Year One To Year Three
LesseeOperatingLeaseLiabilityPaymentsYearOneToYearThree
4510000
CY2021Q4 bcbp Lessee Operating Lease Liability Payments Year One To Year Three
LesseeOperatingLeaseLiabilityPaymentsYearOneToYearThree
4455000
CY2022Q2 bcbp Lessee Operating Lease Liability Payments Year Three To Year Five
LesseeOperatingLeaseLiabilityPaymentsYearThreeToYearFive
3226000
CY2021Q4 bcbp Lessee Operating Lease Liability Payments Year Three To Year Five
LesseeOperatingLeaseLiabilityPaymentsYearThreeToYearFive
3012000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
3062000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
13461000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
13825000
CY2022Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
965000
CY2021Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1073000
CY2022Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
12496000
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
12752000

Files In Submission

Name View Source Status
0001228454-22-000029-index-headers.html Edgar Link pending
0001228454-22-000029-index.html Edgar Link pending
0001228454-22-000029.txt Edgar Link pending
0001228454-22-000029-xbrl.zip Edgar Link pending
bcbp-20220630.xsd Edgar Link pending
bcbp-20220630x10q.htm Edgar Link pending
bcbp-20220630x10q_htm.xml Edgar Link completed
bcbp-20220630xex31_1.htm Edgar Link pending
bcbp-20220630xex31_2.htm Edgar Link pending
bcbp-20220630xex32.htm Edgar Link pending
bcbp-20220630_cal.xml Edgar Link unprocessable
bcbp-20220630_def.xml Edgar Link unprocessable
bcbp-20220630_lab.xml Edgar Link unprocessable
bcbp-20220630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending